The Foundation has laid a solid scientific base upon which pharmaceutical and biotechnology firms can now build retinal degeneration research programs. With help from industry, promising experimental therapies can now advance to clinical trials. As a scientist who has devoted his career to finding treatments and cures for retinal degenerative diseases, it is exciting to catch glimpses of a near future filled with clinical trials.
Back to Main Research Page
Return to Top of Page
comments to email@example.com
Date last modified March 12, 2000